Analyst Ratings for Talis Biomedical Corp. (TLIS) [Sells]
TLIS Rating Summary
TLIS Price Target Summary
- Highest: $5.00 (BTIG)
- Lowest: $5.00 (BTIG)
- Average: $5.00
* Over Last 12-Mos
Overall Rating:
SELL
Rating Trend:
=
Avg. $ Target:
$5.00 (-43.7%)
* Over Last 12-Mos
Rating Score: 0 / 10 Percentile Rank: 0%
Rating Score: 0 / 10 Percentile Rank: 0%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/18/2022 | BTIG » Updated 8/16/2023 |
Mark A. Massaro | Downgrade | Sell (Neutral) |
5.00 (0.35) |
1.42 (8.88) |
525.35% | Details |
1/7/2022 | BofA Securities | Derik de Bruin | Downgrade | Underperform (Neutral) |
3.00 (N/A) |
3.53 (8.88) |
151.56% | Details |